Answer
Yes, concomitant administration of rifampicin, a potent CYP3A4 inducer, with midostaurin (Rydapt) is contraindicated.
Sources for this answer
- Rydapt 25 mg soft capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.3 Contraindications · Version 10Document updated
Sources checked